Archive > December 2011

Facebook VS Google

admin » 31 December 2011 » In Google, Internet, Search Engines, Social Media, Tech News » No Comments

Facebook VS Google

facebook vs google

For the past couple of years, one meme has grown ever louder:

Facebook is killing Google.

Facebook is taking over the Internet, this story goes. Facebook now has ~800 million global users, half of whom log in every day. Facebook now accounts for something like a third of all pageviews in the U.S. Google is miles behind in social, despite the huge numbers for Google +. Facebook consumes an astonishing percentage of time spent online.

And so on.

And most importantly for the Facebook-is-killing-Google meme:

Facebook (and Twitter) are now the means by which many people share content online.

And all of that is true.

But none of it means that Facebook is killing Google.

To get a quick reality check on whether Facebook is killing Google, all you need to do is glance at these two numbers:

$40 Billion
$4 Billion

What are those two numbers?

Those are the approximate revenue numbers for 2011 for Google and Facebook respectively.

Google’s 2011 revenue will be about $40 billion, Facebook’s will be about $4 billion. Google, in other words, is 10-times Facebook’s size.

But, but, but, you say…

Google is still 10-times Facebook’s size because Facebook is just in the early stages of generating revenue. When Facebook gets its revenue engines really cranking, it will blow past Google in no time.

No, it won’t. Not unless it figures out a way to insert itself between consumers who want to buy specific products and companies that make and sell those specific products, the way Google has.

If Facebook builds a products and services search engine, for example, and somehow captures a huge amount of Google’s global search share then, yes, Facebook will in fact be “killing” Google.

Until then, all the “time spent” and “pageviews” and “users” metrics are pretty much irrelevant.


Because as the current revenue levels for both companies are demonstrating, search is a vastly better advertising product than social networking.

Vastly better.

So much better, in fact, that, when it comes to head-to-head business competition, the two companies aren’t yet even in the same league.

And why is search such a better business than social networking?

Because search is the best advertising product in the history of the world.

Social networking, meanwhile, is a relatively lousy advertising product (relatively).

Read more:

Continue reading...

Tags: , , ,

Pfizer Jury Awards $72 Million After Finding Prempro Caused Breast Cancer

admin » 06 December 2011 » In FDA, Legal News, Mass Tort, Verdicts » No Comments

Pfizer Jury Awards $72 Million After Finding Prempro Caused Breast Cancer

Pfizer Inc. (PFE) must pay $72.6 million in damages to three women who contended they developed breast cancer after taking the company’s menopause drugs, a Philadelphia jury decided.

Jurors in state court deliberated over two days before finding today that hormone-replacement drugs made by Pfizer’s Wyeth and Pharmacia Upjohn units were responsible for cancer in Susan Elfont, Bernadette Kalenkoski and Judy Mulderig. The panel awarded Elfont $20 million; Kalenkoski, $27.85 million; and Mulderig, $24.75 million.

“We are obviously disappointed with the verdict in this case, Chris Loder, a Pfizer spokesman, said in a written statement. “Once the verdict is finalized, the company will weigh its legal options to determine how it will continue with the case.”

More than 6 million women took Prempro and related menopause drugs to treat symptoms such as hot flashes and mood swings before a 2002 study highlighted their links to cancer. Wyeth’s sales of the medicines, which are still on the market, topped $2 billion before the release of the Women’s Health Initiative, a National Institutes of Health-sponsored study.

Until 1995, many menopausal women combined Premarin, Wyeth’s estrogen-based drug, with progestin-laden Provera, made by Pfizer’s Upjohn unit, to relieve their symptoms. Wyeth combined the two hormones in its Prempro pill.

Prempro Accords

Pfizer announced in May it had settled a third of the pending Prempro cases filed against it and had set aside $772 million to help resolve the claims.

Elfont, 66, is a former teacher who once lived in Northeast Philadelphia, Tobi Millrood, a lawyer for the three women, said during the trial. She took Premarin and Provera for more than two years before being diagnosed with breast cancer in 1997, Millrood said.

Kalenkoski, 68, is a former nursing home aide who took Prempro for more than four years and was diagnosed with cancer in 2002, Millrood said.

Mulderig, 68, a retired teacher from Carlisle, Pennsylvania, took Premarin and Provera for 11 years starting in 1988.
Millrood told jurors that none of the three women had a family history of breast cancer and experts concluded the women’s use of menopause drugs helped lead to the development of the disease. Millrood today declined to comment immediately.


Continue reading...

Tags: , , ,